Successful phase 2 results in Huntington disease trial
24 February, 2014Prana Biotechnology has announced the results of its phase 2 clinical trial investigating the drug PBT2 as a treatment for Huntington disease.
Giant Magellan Telescope passes design and construction reviews
24 February, 2014The Giant Magellan Telescope (GMT) project has passed two major expert reviews over its design and construction. This clears the way for the project to proceed towards construction approval.
What paused evolution?
21 February, 2014The first life on Earth developed in the ancient oceans around 3.6 billion years ago but remained as little more than a layer of slime for a billion years. An international team of researchers has now revealed the ancient conditions that caused these events to occur.
Starving melanoma cells
19 February, 2014Researchers from the Centenary Institute and the University of Sydney have suggested that it could be possible to treat melanoma by cutting off its food source.
Lower BMI equals fewer nasal bacteria in men
19 February, 2014Researchers from the University of Wroclaw have found a link between body mass index (BMI) and the number of bacteria colonising noses.
Not proof of life on Mars or even Elvis sending messages via doughnuts
17 February, 2014The source of the magically appearing rock on Mars has been revealed.
€85 million to fight Gram-negative pathogens
13 February, 2014Over 30 European universities, research institutes and companies are joining forces in a six-year, €85 million program to develop novel antibiotics against Gram-negative pathogens.
What killed Knut, Berlin Zoo's polar bear?
07 February, 2014After one of the most intensive investigations in veterinary history for a single animal, what caused the death of Berlin Zoological Garden's polar bear, Knut, has been revealed.
Developing single-dose vaccines for cattle
06 February, 2014Researchers at The University of Queensland (UQ) are working on a single-dose (shelf-stable) vaccine that could be used to prevent common cattle diseases and reduce vaccination costs.
Identifying staph with a beacon, not a biopsy
04 February, 2014Researchers at the University of Iowa (UI) have created a probe that can detect a common strain of staph bacteria (Staphylococcus aureus) in the body. Their method has been published in the journal Nature Medicine.
Positive phase 1 results for Admedus herpes trial
03 February, 2014Healthcare company Admedus today announced interim study results on its phase 1 trial of a therapeutic vaccine for herpes simplex virus (HSV-2). The vaccine was found to be safe in the study subjects and was able to generate a T-cell response.
Immunotherapy is paying off at last
03 February, 2014Detect, destroy, remember is the mantra of the immune system as it campaigns against infectious invaders and the body's own abnormal cells. And now immunotherapy is finally offering viable treatment options for some cancers.
Seminal fluid shapes health of offspring
31 January, 2014Researchers from the University of Adelaide's Robinson Institute have discovered that a man's seminal fluid plays a major role in various developmental stages of his offspring, including future health conditions. Their research has been published in Proceedings of the National Academy of Sciences.
Modelling ovarian cancer
29 January, 2014Scientists at Queensland University of Technology (QUT), funded by Cancer Council Queensland, are conducting research into the deadliest form of ovarian cancer.
Old trees continue to grow and store more carbon
22 January, 2014An international study has found that trees do not slow in their growth rate as they get older and larger. In some cases, large trees appear to be adding the carbon mass equivalent of an entire mid-sized tree each year and are thus better at absorbing carbon from the atmosphere than previously thought.
